What You Should Know:

您应该知道：

–       Ciba Health, a cutting-edge digital health company simplifying healthcare with a personalized, whole person-care approach to prevent and reverse chronic diseases through root-cause treatment, today announced rapid growth and an expansion to its leadership team on the heels of its $10M Series A funding..

–Ciba Health是一家尖端数字健康公司，它通过个性化的全人护理方法简化医疗保健，通过根本原因治疗预防和逆转慢性病，今天宣布快速增长，并在其1000万美元的a系列资金之后扩展其领导团队。。

–       Ciba Health raised an oversubscribed $10M Series A funding round led by DigiTx Partners, with participation from E12 Ventures, 3CC Capital, Plug and Play Ventures and angel investors.

–汽巴健康在DigiTx Partners的带领下，在E12 Ventures、3CC Capital、即插即用风投和天使投资者的参与下，筹集了一轮超额认购的1000万美元A系列融资。

Ciba Health Elevates Leadership Team to Drive Innovation in Whole Person-Care Revolution

汽巴健康提升领导团队，推动全人护理革命的创新

Ciba Health, a pioneer in whole person-care disrupting traditional healthcare with a root-cause approach, has announced key appointments to its leadership team. Nwamaka Imasogie, formerly a Principal Software Engineer on the healthcare AI team at Microsoft, joins as Chief Technology Officer, while Roger Chahine has been promoted from Chief Strategy and Operating Officer to President.

汽巴健康（Ciba Health）是以根本原因方法颠覆传统医疗保健的全人护理领域的先驱，已宣布任命其领导团队的关键成员。前微软医疗保健人工智能团队首席软件工程师Nwamaka Imasogie加入首席技术官一职，而Roger Chahine已从首席战略官和运营官晋升为总裁。

Imasogie and Chahine bring with them extensive technology and healthcare expertise, fortifying Ciba Health’s position as an industry leader..

Imasogie和Chahine带来了广泛的技术和医疗保健专业知识，巩固了汽巴健康作为行业领导者的地位。。

The company’s innovative approach combines expert care teams, advanced lab testing, and a root-cause methodology to revolutionize the prevention and treatment of chronic diseases like type 2 diabetes and digestive health issues. With a focus on accelerating product development and scaling operations to meet burgeoning market demand, Ciba Health bridges gaps between primary providers and specialists to deliver personalized, comprehensive care programs.

该公司的创新方法结合了专家护理团队、先进的实验室检测和根本原因方法，彻底改变了2型糖尿病和消化系统健康问题等慢性疾病的预防和治疗。Ciba Health致力于加速产品开发和规模化运营，以满足不断增长的市场需求，弥合初级供应商和专家之间的差距，提供个性化的综合护理计划。

Its onboarding process, including a thorough questionnaire and extensive clinical tests identifying over 300 lab markers, surpasses traditional methods by a significant margin..

它的入职过程，包括一份彻底的问卷调查和广泛的临床测试，确定了300多个实验室标记，大大超过了传统方法。。

Ciba Health’s services extend to both employer-based benefits and individual adults and dependents, currently serving over 97,000 individuals with an impressive provider retention rate of 98%. Since its inception in 2020, the company has experienced remarkable growth, boasting a 100% revenue increase year over year and a 300% surge in platform patients..

汽巴健康的服务扩展到雇主福利以及个人成年人和家属，目前服务于97000多名个人，令人印象深刻的提供者保留率为98%。自2020年成立以来，该公司经历了显着的增长，收入同比增长100%，平台患者激增300%。。

Imasogie, previously Chief Technology Officer at an AI medical software company, brings a track record of rapid product development to her new role, where she will drive scalability through algorithmic implementation and streamlined processes. Chahine, with experience as a Founding Partner at Day223 Ventures, will lead business development efforts and international expansion as President of Ciba Health..

曾任人工智能医疗软件公司首席技术官的伊玛索吉（Imasogie）为她的新角色带来了快速产品开发的记录，她将通过算法实现和简化流程来推动可扩展性。Chahine拥有Day223 Ventures创始合伙人的经验，将作为汽巴健康总裁领导业务发展和国际扩张。。

Recent initiatives include the launch of a Pediatric Metabolic Program in March, catering to children aged five and older, and strategic partnerships with Instacart Health and Solera Health to enhance nutrition services and expand employer offerings. Ciba Health plans to further revolutionize the digital health sector by fostering high-touch, technology-driven solutions and expanding collaborations with third-party administrators and health plans..

最近的举措包括在3月份启动一项儿科代谢计划，以照顾5岁及以上的儿童，并与Instacart Health和Solera Health建立战略伙伴关系，以加强营养服务并扩大雇主的服务范围。汽巴健康计划通过促进高接触、技术驱动的解决方案以及扩大与第三方管理人员和健康计划的合作，进一步彻底改变数字健康部门。。

“We are thrilled to have secured this investment from such a respected group of investors,” said Dr. Innocent Clement, CEO of Ciba Health. “Their support validates our vision and commitment to creating a healthcare system with no gaps, so patients and their providers have all the information needed to treat and reverse chronic diseases with a more holistic approach.

“我们很高兴能从如此受人尊敬的一群投资者那里获得这项投资，”Dr。Ciba Health首席执行官Innocent Clement。“他们的支持验证了我们创建一个没有差距的医疗保健系统的愿景和承诺，因此患者及其提供者拥有以更全面的方法治疗和逆转慢性病所需的所有信息。

We will leverage this funding to drive the growth of our platform and make a meaningful impact on the lives of patients worldwide through a root-cause medicinal approach.”.

我们将利用这笔资金推动我们平台的发展，并通过根本原因医学方法对全球患者的生活产生有意义的影响。”。